Холтеровское мониторирование, 2013. Российский кардиологический журнал
 Скачать 0.68 Mb.
|
|
№ 2 (106) | 2014 66 262. Nierop P, van Mechelen R, Elsacker A, Luijten RH, Elhendy A. Heart rhythm during syncope and presyncope: results of implantable loop recorders. Pacing Clin Electrophysiol 2000;23:1532–1538. 263. Boersma L, Mont L, Sionis A, Garcia E, Brugada J. Value of implantable loop recorder for the management of patients with unexplained syncope. Europace 2004;6:70–76. 264. Lombardi F, Calosso E, Mascioli G, et al. Utility of implantable loop recorder (Reveal Plus) in the diagnosis of unexplained syncope Europace 2005;7:19–24. 265. Pierre B, Fauchier L, Breard L, et al. Implantable loop recorder for recurrent syncope: influence of cardiac conduction abnormalities showing up on resting electrocardiogram and of underlying cardiac disease on follow-up developments. Europace 2008;10:477– 481. 266. Kenny RA, Richardson DA, Steen N, et al. Carotid sinus syndrome: a modifiable risk factor for nonaccidental falls in older adults (SAFE PACE). J Am Coll Cardiol 2001;38:1491–1496. 267. Rothman SA, Laughlin JC, Seltzer J, et al. The diagnosis of cardiac arrhythmias: a prospective multi-center randomized study comparing mobile cardiac outpatient telemetry versus standard loop event monitoring. J Cardiovasc Electrophysiol 2007;18:241–247. 268. Krahn AD, Klein GJ, Yee R, Hoch JS, Skanes AC. Cost implications of testing strategy in patients with syncope: randomized assessment of syncope trial. J Am Coll Cardiol 2003;42:495–501. 269. Hindricks G, Pokushalov E, Urban L, et al. Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: Results of the XPECT trial// Circ Arrhythm Electrophysiol. — 2010;3 (2):141–147. 270. Brignole M, Alboni P, Benditt D, et al. Guidelines on management (diagnosis and treatment) of syncope — Update 2004. — Europace 2004;6:467–537. 271. Zaidi A, Clough P, Cooper P, et al. Misdiagnosis of epilepsy: many seizure-like attacks have a cardiovascular cause. J Am Coll Cardiol 2000;36:181–184. 272. Kenny RA, Richardson DA, Steen N, Bexton RS, Shaw FE, Bond J. Carotid sinus syndrome: a modifiable risk factor for nonaccidental falls in older adults (SAFE PACE). J Am Coll Cardiol 2001;38:1491–1496. 273. Chuang JH, Soren K. Fever, cough, and syncope in a critically ill adolescent. Adolesc Med State Art Rev. 2012;23 (2):260–5. 274. Коростовцев Д. Д. Аффективно-респираторные припадки. В Гузева В. И. Эпилепсия и неэпилептические пароксизмальные состояний у детей Медицинское информационное агентство, 2007, с. Татарский Б. А. Бессимптомная форма фибрилляции предсердий. Сердечная недостаточность treatment of symptomatic atrial fibrillation: a randomized trial//JAMA –2005;293:2634–2640. 277. Jabaudon D. et al Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. — Stroke. 2004;35:1647. 278. Wolf, P. A., Abbott R. D., et al. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22 (8):983–8. 279. Albers G. Amarenco P., et al. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. — Chest. 2004; 126 (3):483–512. 280. Fuster, V., Ryden LE., et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines: developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. — Circulation 2006;114 (7):257–354. 281. Richard L. Page: Newly Diagnosed Atrial Fibrillation. N. Engl.J.Med. 2004;351:2408– 2416. 282. Селина ВВ, Туров АН, Романов АБ. и соавт. Клиническая эффективность длительного подкожного мониторирования ЭКГ у пациентов с фибрилляцией предсердий. Вестник аритмологии 2011;63: 16–22. 283. Елесин ДА, Романов АБ, Туров АН и соавт. Радиочастотная аблация пароксизмальной и длительно-персистирующей форм фибрилляции предсердий:1-летний период наблюдения с помощью системы непрерывного подкожного мониторирования. Вестник аритмологии 2011;63: 5–12. 284. 284. Kirchhof P, Bax J, Blomstrom-Lundquist C, et al.: Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET Europace 2009;11:860–885. 285. Kirchhof P, Auricchio A, Bax J, et al. Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. — Europace 2007;9:1006–1023. 286. Myerburg RJ, Castellanos A. Cardiac arrest and sudden cardiac death. In: Braunwald E, ed., Heart disease: a textbook of cardiovascular medicine. New York: WB Saunders Publishing Co, 1997: 742–79. 287. Gillum RF. Sudden coronary death in the United States: 1980–1985. Circulation 1989;79:756–65. 234. Sheldon R, Rose S, Ritchie D, et al. Historical criteria that distinguish syncope from seizures. J Am Coll Cardiol 2002;40:142–148. 235. Alboni P, Brignole M, Menozzi C, et al. Diagnostic value of history in patients with syncope with or without heart disease. J Am Coll Cardiol 2001;37:1921–1928. 236. Croci F, Brignole M, Alboni P, et al. The application of a standardized strategy of evaluation in patients with syncope referred to three Syncope Units. Europace 2002;4:351–356. 237. Gibson T. C., Heitzman M. R. Diagnostic efficacy of 24-hour electrocardiographic monitoring for syncope. Am J Cardiol 1984, 53:1013–1017. 238. Kala R., Viitasalo M. T., Toivonen L. Eisalo A. Ambulatory ECG recording in patients referred because of syncope or dizziness. Acta Med Scand Suppl 1982; 668:13–19. 239. Boudoulas H., Schaal S. F., Lewis R. P., Robinson J. Superiority of 24-hour outpatient monitoring over multi-stage exercise testing for the evaluation of syncope. J Electrocardiol 1979; 12:103–108. 240. Brignole M., Moya A., Menozzi C., R. Garcia-Civera., Sutton R. Proposed eletrocardiographik classification of spontaneous syncope documented by an implatable loop recorder. Europace 2005; 7: 14–18. 241. Wieling W, Ganzeboom KS, Saul JP. Reflex syncope in children and adolescents. Heart 2004;90:1094–1100. 242. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. J Neurol Sci 1996;144:218–219. 243. Krahn AD, Klein GL, Tee R, Skanes AC. Detection of asymptomatic arrhythmias in unexplained syncope. Am Heart J 2004;148:326–332. 244. Ermis C, Zhu AX, Pham S, et al. Comparison of automatic and patientactivated arrhythmia recordings by implantable loop recorders in the evaluation of syncope. Am J Cardiol 2003;92:815–819. 245. Moya A, Brignole M, Sutton R, et al. Reproducibility of electrocardiographic findings in patients with neurally-mediated syncope. Am J Cardiol 2008;102:1518–1523. 246. Moya А, Sutton R, Ammirati F, et al. Guidelines for the diagnosis and management of syncope (version 2009). The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC). European Heart Journal 2009;27. 247. Moya A, Brignole M, Menozzi C, et al. Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation 2001;104:1261–1267. 248. Solano A, Menozzi C, Maggi R, et al. Incidence, diagnostic yield and safety of the implantable loop-recorder to detect the mechanism of syncope in patients with and without structural heart disease. Eur Heart J 2004;25:1116–1119. 249. Brignole M, Sutton R, Menozzi C, et al. International Study on Syncope of Uncertain Etiology 2 (ISSUE 2) Group. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neutrally mediated syncope. Eur Heart J 2006;27:1085–1092. 250. Pezawas T, Stix G, Kastner J, et al. Implantable loop recorder in unexplained syncope: classification, mechanism, transient loss of consciousness and role of major depressive disorder in patients with and without structural heart disease. Heart 2008;94: e17. 251. Linzer M, Pritchett EL, Pontinen M, et al. Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope. Am J Cardiol 1990;66:214– 219. 252. Schuchert A, Maas R, Kretzschmar C, et al. Diagnostic yield of external loop recorders in patients with recurrent syncope and negative tilt table test. Pacing Clin Electrophysiol 2003;26:1837–1840. 253. Rockx MA, Hoch JS, Klein GJ, Yee R, Skanes AC, Gula LJ, Krahn AD. Is ambulatory monitoring for ‘community-acquired’ syncope economically attractive? A cost- effectiveness analysis of a randomized trial of external loop recorders versus Holter monitoring. Am Heart J 2005;150:1065. 254. Krahn A, Klein G, Norris C, Yee R. The etiology of syncope in patients with negative tilt table and electrophysiologic testing. Circulation 1995;92:1819–1824. 255. Krahn AD, Klein GJ, Yee R, Takle-Newhouse T, Norris C. Use of an extended monitoring strategy in patients with problematic syncope. Reveal Investigators. Circulation 1999; 26:99:406–410. 256. Krahn AD, Klein GL, Tee R, Skanes AC. Detection of asymptomatic arrhythmias in unexplained syncope. Am Heart J 2004;148:326–332. 257. Ermis C, Zhu AX, Pham S, Li JM, Guerrero M, Vrudney A, Hiltner L, Lu F, Sakaguchi S, Lurie KG, Benditt DG. Comparison of automatic and patientactivated arrhythmia recordings by implantable loop recorders in the evaluation of syncope. Am J Cardiol 2003;92:815–819. 258. Krahn A, Klein GJ, Yee R, Skanes AC. Randomized assessment of syncope trial. Conventional diagnostic testing versus a prolonged monitoring strategy. Circulation 2001;104:46–51. 259. Farwell D, Freemantle N, Sulke N. The clinical impact of implantable loop recorders in patients with syncope. Eur Heart J 2006;27:351–356. 260. Menozzi C, Brignole M, Garcia-Civera R, et al. International Study on Syncope of Uncertain Etiology (ISSUE) Investigators. Mechanism of syncope in patients with heart disease and negative electrophysiologic test. Circulation 2002;105:2741–2745. 261. Brignole M, Menozzi C, Moya A, Garcia-Civera R, Mont L, Alvarez M, Errazquin F, Beiras J, Bottoni N, Donateo P; International Study on Syncope of Uncertain Etiology (ISSUE) Investigators. Mechanism of syncope in patients with bundle branch block and negative electrophysiological test. Circulation 2001;104:2045–2050. К 50-ЛЕТИЮ РОССИЙСКОГО КАРДИОЛОГИЧЕСКОГО ОБЩЕСТВА 67 КЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИ. Zuanetti G, Neilson JM, Latini R, et al. Prognostic significance of heart rate variability in post- myocardial infarction patients in the fibrinolytic era.The GISSI-2 results. Gruppo Italiano per lo Studio dellaSopravvivenza nell’ Infarto Miocardico. Circulation 1996;94: 432–36. 316. Malik M, Camm AJ, Janse MJ, Julian DG, Frangin GA, Schwartz PJ. Depressed heart rate variability identifiespostinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial). J Am Coll Cardiol 2000; 35: 1263–75. 317. Maggioni AP, Zuanetti G, Franzosi MG et al. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation 1993; 87: 312–22. 318. Statters DJ, Malik M, Redwood S, Hnatkova K, Staunton A, Camm AJ. Use of ventricular premature complexes for risk stratification after acute myocardial infarction in the thrombolytic era. Am J Cardiol 1996; 77: 133–8. 319. Hohnloser SH, Klingenheben T, Zabel M, Schopperl M, Mauss O. Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era. J Am Coll Cardiol 1999; 33: 1895–902. 320. Steinberg JS, Regan A, Sciacca RR, Bigger JT, Jr, Fleiss JL. Predicting arrhythmic events after acute myocardial infarction using the signal-averaged electrocardiogram. Am J Cardiol 1992; 69: 13–21. 321. Ikeda T, Sakata T, Takami M et al. Combined assessment of T-wave alternans and late potentials used to predict arrhythmic events after myocardial infarction. A prospective study. J Am Coll Cardiol 2000; 35: 722–30. 322. Schwartz PJ, Wolf S. QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation 1978; 57: 1074–7. 323. Schmidt G, Malik M, Barthel P et al. Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet 1999; 353: 1390–6. 324. Zabel M, Klingenheben T, Franz MR, Hohnloser SH. Assessment of QT dispersion for prediction of mortality or arrhythmic events after myocardial infarction: results of a prospective, long-term follow-up study. Circulation 1998; 97: 2543–50. 325. Deanfeild J. E..Myocardial ischemia during daily life in patients with stable angina: its relation to symptoms and heart rate changes. Lancet.1983; 2:753. 326. Biagini A. In Acute transient myocardial ischemia. Ambulatory Monitoring. Cardiovascular System and Allied Applications. Ed. Carlo Marchesi. Martinus Nijhoff Publ. For the commission of the European Communities. Pisa. Apr. 11–12. 1983; 105–113. 327. Национальные рекомендации по лечению ОКС без стойкого подъема ST на ЭКГ. Кардиоваскулярная терапия и профилактика 2006; 5: Приложение 1. 328. Rocco M. B., Nabel E. G., Campbell S. et al. Prognostic importance of myocardial ischemia detected by ambulatory monitoring in patients with stable coronary artery disease. Circulation 1988; 78:877–884. 329. Deedwania P. C. and Carbajal E. V. Silent ischemia during daily life is an independent predictor of mortality in stable angina. Circulation 1990; 81:748–756. 330. Raby K. E., Goldman L., Cook E. F. et al. Long-term prognosis of myocardial ischemia detected by Holter monitoring in peripheral vascular disease. Am J Cardiol 1990; 66:1309–1313. 331. De Marchena E., Asch J., Martinez J. et al. Usefulness of persistent silent myocardial ischemia in predicting a high cardiac event rate in men with medically controlled, stable angina pectoris. Am J Cardiol 1994; 73:390–392. 332. Yeung A. C., Barry J., Orav J. et al. Effects of asymptomatic ischemia on long-term prognosis in chronic stable coronary disease. Circulation 1991; 83:1598–1604. 333. Deedwania P. C. and Carbajal E. V. Usefulness of ambulatory silent myocardial ischemia added to the prognostic value of exercise test parameters in predicting risk of cardiac death in patients with stable angina pectoris and exercise-induced myocardial ischemia. Am J Cardiol 1991;68:1279–1286. 334. Madjlessi-Simon T., Mary-Krause M. et al. Persistent transient myocardial ischemia despite beta-adrenergic blockade predicts a higher risk of adverse cardiac events in patients with coronary artery isease. J Am Coll Cardiol 1996; 27:1586–1591. 335. Huang SK, Messer JV, Denes P. Significance of ventricular tachycardia in idiopathic dilated cardiomyopathy: observations in 35 patients. Am J Cardiol 1983;51:507–12. 336. Kron J, Hart M, Schual-Berke S, et al. Idiopathic dilated cardiomyopathy: role of programmed electrical stimulation and Holter monitoring in predicting those at risk of sudden death. Chest 1988;93: 85–90. 337. Holmes J, Kubo SH, Cody RJ, et al. Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: prediction of mortality by ambulatory electrocardiography. Am J Cardiol 1985;55:146–51. 338. Unverferth DV, Magorien RD, Moeschberger ML, et al. Factors influencing the 1-year mortality of dilated cardiomyopathy. Am J Cardiol 1984;54:147–52. 339. Ikegawa T, Chino M, Hasegawa H, et al. Prognostic significance of 24-hour ambulatory electrocardiographic monitoring in patients with dilative cardiomyopathy: a prospective study. Clin Cardiol 1987;10: 78–82. 340. Szabo BM, van Veldhuisen DJ, Crijns HJ, et al. Value of ambulatory electrocardiographic monitoring to identify risk of sudden death in patients with left ventricular dysfunction and heart failure. Eur Heart J 1994;15:928–33. 288. Escobedo LG, Zack MM. Comparison of sudden and nonsudden coronary deaths in the United States. Circulation 1996;93:2033–6. 289. Zheng ZJ, Croft JB, Giles WH, et al. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001;104:2158–63. 290. Carveth SW, Olson D, Bechtel J. Proceedings: Emergency medical care system. Lincoln (Beb) mobile heart team. Arch Surg 1974; 108: 528–30. 291. Vertesi L. The paramedic ambulance: a Canadian experience. Can Med Assoc J 1978; 119:25–9. 292. Bikkina M, Larson MG, Levy D. Prognostic implications of asymptomatic ventricular arrhythmias: the Framingham Heart Study. Ann Intern Med 1992;117:990–6. 293. Myerburg RRJ. Scientific gaps in the prediction and prevention of sudden cardiac death. J Cardiovacular Electrophysiol. 2002;13:709–723. 294. De Vreede-Swagemakers J., Gorders A., Van Ree J. Circumstances and causes of out – of-hospital cardiac arrest in sudden death survivors. Heart 1998, 79:356–361. 295. Макаров Л. М, Солохин Ю. А. Внезапная внебольничная сердечная смерть у детей, подростков и лиц молодого возраста. Кардиология 2009:11; 33–37 296. Солохин Ю. А, Макаров Л. М. Анализ внезапной внегоспитальной сердечной смерти у детей, подростков и молодых лиц. Альманах судебной медицины. 2009; 4 (12): 19–24. 297. Solokhin Y, Makarov L, Zaklyazminskaya E. Complex approaches to diagnostic reason for sudden out of hospital cardiac death in children, adolescents, and younger people during forensic medical examination. Abstracts of 14th CONGRESS OF INTERNATIONAL SOCIETY FOR HOLTER AND NONINVASIVE ELECTROCARDIOLOGY (ISHNE). P-3–092, Moscow 26–28.04.2011, p. 98. 298. Солохин Ю. А, Макаров Л. М, Комолятова В. Н. Внезапная внегоспитальная сердечная смерть в молодом возрасте (анализ залет поданным го танато- логического отделения бюро Судебно-медицинской экспертизы Департамента Здравоохранения г. Москвы. Медицинская экспертиза и право (2012 г, в печати. Bigger JT Jr, Fleiss JL, Kleiger R, et al. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 1984;69:250–8. 300. Multicenter Post-infarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983;309 (6):331–6. 301. McClements BM, Adgey AA. Value of signal-averaged electrocardiography, radionuclide ventriculography, Holter monitoring and clinical variables for prediction of arrhythmic events in survivors of acute myocardial infarction in the thrombolytic era. J Am Coll Cardiol 1993;21:1419–27. 302. Hohnloser SH, Franck P, Klingenheben T, et al. Open infarct artery, late potentials, and other prognostic factors in patients after acute myocardial infarction in the thrombolytic era: a prospective trial. Circulation 1994;90:1747–1756. 303. Cairns JA, Connolly SJ, Roberts R, et al. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT, Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet 1997;349:675–82. 304. Farrell TG, Bashir Y, Cripps T, et al. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory lectrocardiographic variables and the signalaveraged electrocardiogram. J Am Coll Cardiol 1991;18:687–97. 305. El-Sherif N, Denes P, Katz R, et al. Definition of the best prediction criteria of the time domain signal-averaged electrocardiogram for serious arrhythmic events in the postinfarction period: the Cardiac Arrhythmia Suppression Trial/Signal-Averaged Electrocardiogram (CAST/SAECG) Substudy Investigators. J Am Coll Cardiol 1995; 25:908–14. 306. Davis BR, Friedman LM, Lichstein E. The prognostic value of the duration of the ambulatory electrocardiogram after myocardial infarction.Med Decis Making 1988;8:9–18. 307. Davis BR, Friedman LM, Lichstein E. Are 24 hours of ambulatory ECG monitoring necessary for a patient after infarction? Am Heart J 1988;115:83–91. 308. Dittrich H, Gilpin E, Nicod P, et al. Acute myocardial infarction in women: influence of gender on mortality and prognostic variables.Am J Cardiol 1988;62:1–7. 309. Pedretti R, Etro MD, Laporta A, et al. Prediction of late arrhythmic events after acute myocardial infarction from combined use of noninvasive prognostic variables and inducibility of sustained monomorphic entricular tachycardia. Am J Cardiol 1993;71:1131–41. 310. Zhang YZ, Wang SW, Hu DY, et al. Prediction of life-threatening arrhythmia in patients after myocardial infarction by late potentials, ejection fraction and Holter monitoring. Jpn Heart J 1992;33:15–23. 311. Kleiger RE, Miller JP, Bigger JT, et al. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987;59:256–62. 312. Odemuyiwa O, Malik M, Farrell T, et al. Comparison of the predictive characteristics of heart rate variability index and left ventricular ejection fraction for all-cause mortality, arrhythmic events and sudden death after acute myocardial infarction. Am J Cardiol 1991;68:434–9. 313. Bigger JT, Fleiss JL, Steinman RC, et al. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992;85:164–71. 314. La Rovere MT, Bigger JT Jr, Marcus FI, et al. Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction: ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998;351:478–84. |